These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

220 related items for PubMed ID: 3388844

  • 21. Identification of a prodromal period in Crohn's disease but not ulcerative colitis.
    Pimentel M, Chang M, Chow EJ, Tabibzadeh S, Kirit-Kiriak V, Targan SR, Lin HC.
    Am J Gastroenterol; 2000 Dec; 95(12):3458-62. PubMed ID: 11151877
    [Abstract] [Full Text] [Related]

  • 22. Inflammatory mediators and acute phase proteins in patients with Crohn's disease and ulcerative colitis.
    Niederau C, Backmerhoff F, Schumacher B, Niederau C.
    Hepatogastroenterology; 1997 Dec; 44(13):90-107. PubMed ID: 9058126
    [Abstract] [Full Text] [Related]

  • 23. C-reactive protein: a predictive factor and marker of inflammation in inflammatory bowel disease. Results from a prospective population-based study.
    Henriksen M, Jahnsen J, Lygren I, Stray N, Sauar J, Vatn MH, Moum B, IBSEN Study Group.
    Gut; 2008 Nov; 57(11):1518-23. PubMed ID: 18566104
    [Abstract] [Full Text] [Related]

  • 24. Antibodies to Saccharomyces cerevisiae: are they useful in clinical practice?
    Candelli M, Papa A, Nista EC, Danese S, Armuzzi A, Bartolozzi F, Tondi P, Ojetti V, Gasbarrini G, Gasbarrini A.
    Hepatogastroenterology; 2003 Nov; 50(51):718-20. PubMed ID: 12828069
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Low prevalence of anti-neutrophil cytoplasmic antibodies in ulcerative colitis patients with long-term remission.
    Lindgren S, Florén CH, Lindhagen T, Starck M, Stewenius J, Nässberger L.
    Eur J Gastroenterol Hepatol; 1995 Jun; 7(6):563-8. PubMed ID: 7552641
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Immunohistochemical localization of vascular endothelial growth factor in colonic mucosa of patients with inflammatory bowel disease.
    Griga T, May B, Pfisterer O, Müller KM, Brasch F.
    Hepatogastroenterology; 2002 Jun; 49(43):116-23. PubMed ID: 11941933
    [Abstract] [Full Text] [Related]

  • 29. Anti-neutrophil cytoplasmic antibodies in Brazilian patients with inflammatory bowel disease.
    Cabral VL, Miszputen SJ, Catapani WR.
    Hepatogastroenterology; 2003 Jun; 50(50):412-5. PubMed ID: 12749235
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Paediatric inflammatory bowel disease in New Zealand.
    Yap J, Wesley A, Mouat S, Chin S.
    N Z Med J; 2008 Oct 03; 121(1283):19-34. PubMed ID: 18841182
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Cellular immune reactions against common antigen, small intestine, and colon antigen in patients with Crohn's disease, ulcerative colitis, and cirrhosis of the liver.
    Eckhardt R, Heinisch M, Meyer zum Büschenfelde KH.
    Scand J Gastroenterol; 1976 Oct 03; 11(1):49-54. PubMed ID: 1251132
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.